Pharma & Biotech

Add to MyProactive

Cancer cells

Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year

3 weeks, 6 days ago

brain scan

Kazia Therapeutics launches $25 million capital raise to take glioblastoma candidate paxalisib into pivotal study

3 weeks, 6 days ago

Coronavirus graphic

BioSig subsidiary ViralClear Pharmaceuticals to test its drug merimepodib in a combination coronavirus treatment

4 weeks ago

Valeo Pharma sees a strong outlook for the company after releasing third quarter financial numbers

Valeo Pharma sees a strong outlook for the company after releasing third quarter financial numbers

4 weeks ago

Todos Medical strikes branding and distribution deal with Melbourne Biotech for RT-PCR machines in US

Todos strikes branding and distribution deal with Melbourne Biotech for RT-PCR machines in US

4 weeks ago

Sprouts growing from stacks of quarters leading to a jar of quarters

Valeo Pharma says it is positioned for profit with latest product launches; posts fiscal 3Q results

4 weeks ago

otc

BetterLife Pharma receives FINRA approval to resume trading on OTC Markets

4 weeks ago

Open Orphan PLC - Open Orphan 'period of integration, restructuring and setting the scene' for future growth

Open Orphan first half: 'period of integration, restructuring and setting the scene' for future growth

4 weeks ago

Tiziana Life Sciences PLC - Tiziana eyes progress in drug pipeline after busy six months

Tiziana eyes progress in drug pipeline after busy six months

4 weeks ago

Kazia Therapeutics Ltd - Kazia Therapeutics in trading halt pending announcement relating to entitlement offer outcome of institutional component

Kazia Therapeutics halted with news pending on accelerated entitlement offer

4 weeks ago

IXICO PLC - IXICO plays 'pivotal role' after announcing £2m extension to Huntington's disease study

IXICO plays 'pivotal role' after announcing £2m extension to Huntington's disease study

4 weeks, 1 day ago

Virus graphic

Revive Therapeutics to start enrolling patients in Phase 3 coronavirus trial of Bucillamine

4 weeks, 1 day ago

covid

Algernon enrolls 100 patients for its Phase 2b/3 human study of Ifenprodil to treat COVID-19

4 weeks, 1 day ago

Coronavirus graphic

Lexaria gets ethics board nod for human trial of DehydraTECH drug delivery system; launches rodent trial with COVID-19 drugs

4 weeks, 1 day ago

merger

Orgenesis in deal to acquire regenerative medicine company Koligo Therapeutics

4 weeks, 1 day ago

Acasti Pharma Inc - Acasti Pharma initiates a review process to evaluate strategic alternatives to boost shareholder value

Acasti Pharma initiates review process to evaluate strategic alternatives to boost shareholder value

4 weeks, 1 day ago

Novavax, Inc. - Novavax to present on COVID-19 vaccine candidate this week

Novavax to present on COVID-19 vaccine candidate this week

1 month ago

FSD Pharma - FSD Pharma wins FDA nod to begin Phase 2 clinical trial for its lead drug micro-PEA to treat coronavirus patients

FSD Pharma wins FDA nod to begin Phase 2 clinical trial for its lead drug micro-PEA to treat coronavirus patients

1 month ago

Cardiol Therapeutics - Cardiol gets FDA nod for IND application for Phase II/III COVID-19 trial of lead drug CardiolRx

Cardiol gets FDA nod for IND application for Phase II/III COVID-19 trial of lead drug CardiolRx

on 09/25/2020

Boardroom with three people

Medexus names pharma veteran Michael Pine senior vice president of business development and strategy

on 09/25/2020